3-(n-maleimidopropionyl)biocytin has been researched along with Cognition Disorders in 1 studies
*Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domino, EF; Kawamata, M; Nishiyama, S; Ohba, H; Takei, N; Tsukada, H; Wakuda, T; Yamamoto, S | 1 |
1 other study(ies) available for 3-(n-maleimidopropionyl)biocytin and Cognition Disorders
Article | Year |
---|---|
Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
Topics: Animals; Brain; Brain Mapping; Carbon Isotopes; Cognition Disorders; Consciousness; Disease Models, Animal; Dose-Response Relationship, Drug; Lysine; Macaca mulatta; Magnetic Resonance Imaging; Male; Maleimides; Muscarinic Antagonists; Neuropsychological Tests; Photic Stimulation; Positron-Emission Tomography; Reaction Time; Receptors, Muscarinic; Scopolamine; Time Factors | 2011 |